Your activity: 35426 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: [email protected]

Physiology of the normal menstrual cycle

Physiology of the normal menstrual cycle
Author:
Corrine K Welt, MD
Section Editors:
William F Crowley, Jr, MD
Diane Blake, MD
Deputy Editor:
Kathryn A Martin, MD
Literature review current through: Feb 2022. | This topic last updated: Jun 22, 2021.

INTRODUCTION — The normal menstrual cycle is a tightly coordinated cycle of stimulatory and inhibitory effects that results in the release of a single mature oocyte from a pool of hundreds of thousands of primordial oocytes. A variety of factors contribute to the regulation of this process, including hormones and paracrine and autocrine factors that are still being identified. The cyclic changes in the major pituitary and gonadal hormones are illustrated in the figures (figure 1 and figure 2).

The physiology of the normal menstrual cycle will be discussed here. Detection of ovulation and ultrasound evaluation of the menstrual cycle are reviewed separately. (See "Ultrasound evaluation of the normal menstrual cycle" and "Evaluation of the menstrual cycle and timing of ovulation".)

PHASES AND DURATION OF THE MENSTRUAL CYCLE — By convention, the first day of menses represents the first day of the cycle (day 1). The cycle is then divided into two phases: follicular and luteal.

The follicular phase begins with the onset of menses and ends on the day before the luteinizing hormone (LH) surge.

The luteal phase begins on the day of the LH surge and ends at the onset of the next menses.

The average adult menstrual cycle lasts 28 to 35 days, with approximately 14 to 21 days in the follicular phase and 14 days in the luteal phase [1,2]. There is relatively little cycle variability among women between the ages of 20 and 40 years. In comparison, there is significantly more cycle variability for the first five to seven years after menarche and for the last 10 years before cessation of menses (figure 3) [1].

In general, menstrual cycle length peaks at approximately age 25 to 30 years and then gradually declines so that women in their forties have slightly shorter cycles. Changes in intermenstrual interval are primarily due to changes in the follicular phase; in comparison, the luteal phase remains relatively constant [3].

The remainder of this topic will review the hormonal, ovarian, and endometrial changes that occur during the different phases of the menstrual cycle.

EARLY FOLLICULAR PHASE — The early follicular phase in humans is the time when the ovary is the least hormonally active, resulting in low serum estradiol and progesterone concentrations (figure 1). Release from the negative feedback effects of estradiol, progesterone, and probably luteal phase inhibin A results in a late luteal/early follicular phase increase in gonadotropin-releasing hormone (GnRH) pulse frequency and a subsequent increase in serum follicle-stimulating hormone (FSH) concentrations of approximately 30 percent [4]. This small increase in FSH secretion appears to be required for the recruitment of the next cohort of developing follicles, one of which will become the dominant and ultimately ovulatory follicle during that cycle [5-7].

Serum inhibin B concentrations, secreted by the recruitable pool of small follicles, are maximal and may play a role in suppressing the FSH rise at this time in the cycle (figure 4) [8]. There is also a rapid increase in luteinizing hormone (LH) pulse frequency at this time, from one pulse every four hours in the late luteal phase to one pulse every 90 minutes in the early follicular phase [9].

The early follicular phase is also associated with a unique neuroendocrine phenomenon: slowing or cessation of LH pulses during sleep that does not occur at other times of the menstrual cycle (figure 5). How this occurs is not known.

Serum anti-müllerian hormone (AMH) has been used as a potential marker of ovarian health and aging. It is secreted by small antral follicles and correlates with the total number of ovarian antral follicles. The variability of serum AMH across the menstrual cycle appears to be minimal [10]. (See "Evaluation of female infertility", section on 'Anti-müllerian hormone' and "Ovarian development and failure (menopause) in normal women", section on 'Menopause'.)

Ovaries and endometrium — Ovarian ultrasonography has demonstrated that the ovary is quiescent in the early follicular phase, except for the occasionally visible resolving corpus luteum from the previous cycle. The endometrium is relatively indistinct during menses and then becomes a thin line once menses is complete. It is normal to see small follicles of 3 to 8 mm in diameter at this time. (See "Ultrasound evaluation of the normal menstrual cycle".)

MID-FOLLICULAR PHASE — The modest increase in follicle-stimulating hormone (FSH) secretion in the early follicular phase gradually stimulates folliculogenesis and estradiol production, leading to progressive growth of the cohort of follicles selected that cycle. As several follicles initially grow to the antral stage, their granulosa cells hypertrophy and divide, producing increasing serum concentrations of estradiol via FSH stimulation of aromatase and then inhibin A from the granulosa cells in the ovaries.

The increase in estradiol production feeds back negatively on the hypothalamus and pituitary, resulting in suppression of mean serum FSH and luteinizing hormone (LH) concentrations as well as the LH pulse amplitude. In comparison, the gonadotropin-releasing hormone (GnRH) pulse generator speeds up slightly to a mean LH pulse frequency of approximately one per hour (versus one per 90 minutes in the early follicular phase). GnRH stimulation is presumably due to release of negative feedback effects of progesterone from the previous luteal phase. (See "Physiology of gonadotropin-releasing hormone".)

Ovarian and endometrial changes — Within approximately seven days from the onset of menses, several 9 to 10 mm antral follicles are visible on ovarian ultrasonography. The rising serum estradiol concentrations result in proliferation of the uterine endometrium, which becomes thicker, with an increase in the number of glands and the development of a "triple stripe" pattern on ultrasound (figure 2) [11]. (See "Ultrasound evaluation of the normal menstrual cycle".)

LATE FOLLICULAR PHASE — The serum concentrations of estradiol and inhibin A increase daily during the week before ovulation due to release from the growing follicle. Serum follicle-stimulating hormone (FSH) and luteinizing hormone (LH) concentrations are falling at this time due to negative feedback effects of estradiol and perhaps other hormones released from the ovary (figure 1). As the dominant follicle is selected, FSH induces LH receptors in the ovary and increases ovarian secretion of intrauterine growth factors such as insulin-like growth factor-1 (IGF-1).

Ovarian, endometrial, and cervical mucus changes — By the late follicular phase, a single dominant follicle has been selected, while the rest of the growing cohort of follicles gradually stop developing and undergo atresia. The dominant follicle increases in size by approximately 2 mm per day until a mature size of 20 to 26 mm is reached. (See "Ultrasound evaluation of the normal menstrual cycle".)

Rising serum estradiol concentrations result in gradual thickening of the uterine endometrium and an increase in the amount and "stringiness" (spinnbarkeit) of the cervical mucus. Many women are able to detect this change in mucus character. Studies of cervical mucus samples during the menstrual cycle demonstrate a late follicular-phase peak in the mucin protein MUC5B that may be important for sperm transit to the uterus [12].

MIDCYCLE SURGE AND OVULATION — Serum estradiol concentrations continue to rise until they reach a peak approximately one day before ovulation. Then, a unique neuroendocrine phenomenon occurs: the midcycle surge [13]. The surge represents a switch from negative feedback control of luteinizing hormone (LH) secretion by ovarian hormones (such as estradiol and progesterone) to a sudden positive feedback effect, resulting in a 10-fold increase in serum LH concentrations and a smaller rise in serum follicle-stimulating hormone (FSH) concentrations (figure 1). In addition to estrogen and progesterone, other ovarian factors contribute to the LH surge because it cannot be recreated simply by administering estrogen and a progestin to women in the early to mid-follicular phase to achieve serum concentrations similar to those at the midcycle [14].

At this time, the frequency of LH pulses continues to be approximately one per hour, but the amplitude of the LH pulses increases dramatically. The switch from negative to positive feedback of LH release is poorly understood. An increase in the number of pituitary gonadotropin-releasing hormone (GnRH) receptors may contribute, but there is probably no change in GnRH input to the pituitary [15].

Ovarian changes — The LH surge initiates substantial changes in the ovary. The oocyte in the dominant follicle completes its first meiotic division. In addition, the local secretion of plasminogen activator and other cytokines required for the process of ovulation is increased [16,17]. The oocyte is released from the follicle at the surface of the ovary approximately 36 hours after the LH surge. It then travels down the fallopian tube to the uterine cavity. There is a close relation of follicular rupture and oocyte release to the LH surge; as a result, measurements of serum or urine LH can be used to estimate the time of ovulation in women. (See "Evaluation of the menstrual cycle and timing of ovulation".)

Even before the oocyte is released, the granulosa cells surrounding it begin to luteinize and produce progesterone. Progesterone acts rapidly to slow the pulse generator so that LH pulses become less frequent by the termination of the surge.

Endometrium — The gradually increasing serum progesterone concentrations have a profound impact on the endometrial lining, leading to cessation of mitoses and "organization" of the glands [18]. This change can be detected on ultrasonography relatively soon after ovulation; the "triple stripe" image is lost, and the endometrium becomes more uniformly bright (figure 2) [11]. (See "Ultrasound evaluation of the normal menstrual cycle".)

LUTEAL PHASE — Progesterone secretion from the corpus luteum [19] results in gradually rising progesterone concentrations in the middle to late luteal phase. This leads to progressive slowing of luteinizing hormone (LH) pulses down to one pulse every four hours. Pulses of progesterone occur soon after these slow LH pulses. As a result, there can be significant excursions in serum progesterone concentrations during the luteal phase (figure 6) [20]. Inhibin A is also produced by the corpus luteum, and serum concentrations of inhibin A peak in the mid-luteal phase. Inhibin B secretion is virtually absent during the luteal phase (figure 4). Serum leptin concentrations are highest in the luteal phase [21]. (See "Physiology of leptin".)

In the late luteal phase, a decrease in LH secretion results in a gradual fall in progesterone and estradiol production by the corpus luteum in the absence of a fertilized oocyte. If, however, the oocyte becomes fertilized, it implants in the endometrium several days after ovulation. The early embryo begins to make chorionic gonadotropin, which maintains the corpus luteum and progesterone production.

Endometrial changes — The decline in estradiol and progesterone release from the resolving corpus luteum results sequentially in the loss of endometrial blood supply, endometrial sloughing, and the onset of menses approximately 14 days after the LH surge. Menses is a relatively imprecise marker of hormonal events in the menstrual cycle since there is considerable interindividual variability in the relationship between the onset of endometrial sloughing and the fall in serum hormone concentrations during the luteal phase (figure 2) [4].

In response to falling corpus luteum steroid production, the hypothalamic-pituitary axis is released from negative feedback and follicle-stimulating hormone (FSH) levels rise, thereby beginning the next cycle.

SUMMARY — By convention, the first day of menses represents the first day of the cycle (day 1). The cycle is then divided into two phases: follicular and luteal.

The follicular phase begins with the onset of menses and ends on the day before the luteinizing hormone (LH) surge.

The luteal phase begins on the day of the LH surge and ends at the onset of the next menses.

The average adult menstrual cycle lasts 28 to 35 days, with approximately 14 to 21 days in the follicular phase and 14 days in the luteal phase. There is relatively little cycle variability among women between the ages of 20 and 40 years. In comparison, there is significantly more cycle variability for the first five to seven years after menarche and for the last 10 years before cessation of menses (figure 3).

In general, menstrual-cycle length peaks at approximately age 25 to 30 years and then gradually declines so that women in their forties have slightly shorter cycles. Changes in intermenstrual interval are primarily due to changes in the follicular phase; in comparison, the luteal phase remains relatively constant.

REFERENCES

  1. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil 1967; 12:77.
  2. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975; 55:699.
  3. Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976; 42:629.
  4. Hall JE, Schoenfeld DA, Martin KA, Crowley WF Jr. Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J Clin Endocrinol Metab 1992; 74:600.
  5. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986; 1:81.
  6. Gougeon A. Dynamics of human follicular growth: A morphologic perspective. In: The Ovary, Adashi EY, Leung PCK (Eds), Raven Press, New York 1993. p.21.
  7. Welt CK, Martin KA, Taylor AE, et al. Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women. J Clin Endocrinol Metab 1997; 82:2645.
  8. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999; 84:105.
  9. Filicori M, Santoro N, Merriam GR, Crowley WF Jr. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986; 62:1136.
  10. Kissell KA, Danaher MR, Schisterman EF, et al. Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Hum Reprod 2014; 29:1764.
  11. Fleischer AC, Kalemeris GC, Entman SS. Sonographic depiction of the endometrium during normal cycles. Ultrasound Med Biol 1986; 12:271.
  12. Gipson IK, Moccia R, Spurr-Michaud S, et al. The Amount of MUC5B mucin in cervical mucus peaks at midcycle. J Clin Endocrinol Metab 2001; 86:594.
  13. Adams JM, Taylor AE, Schoenfeld DA, et al. The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency. J Clin Endocrinol Metab 1994; 79:858.
  14. Taylor AE, Whitney H, Hall JE, et al. Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women. J Clin Endocrinol Metab 1995; 80:1541.
  15. Martin KA, Welt CK, Taylor AE, et al. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model. Neuroendocrinology 1998; 67:363.
  16. Richards JS. Hormonal control of gene expression in the ovary. Endocr Rev 1994; 15:725.
  17. Tsafriri A, Chun SY, Reich R. Follicular rupture and ovulation. In: The Ovary, Adashi EY, Leung PCK (Eds), Raven Press, New York 1993. p.227.
  18. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3.
  19. Stocco C, Telleria C, Gibori G. The molecular control of corpus luteum formation, function, and regression. Endocr Rev 2007; 28:117.
  20. Filicori M, Butler JP, Crowley WF Jr. Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion. J Clin Invest 1984; 73:1638.
  21. Cella F, Giordano G, Cordera R. Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol 2000; 142:174.
Topic 7418 Version 14.0

References

1 : Variation of the human menstrual cycle through reproductive life.

2 : Hormonal characteristics of the human menstrual cycle throughout reproductive life.

3 : The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations during menstrual cycles of older women.

4 : Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition.

5 : Dynamics of follicular growth in the human: a model from preliminary results.

6 : Dynamics of follicular growth in the human: a model from preliminary results.

7 : Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: evidence for FSH control of inhibin B in normal women.

8 : Female reproductive aging is marked by decreased secretion of dimeric inhibin.

9 : Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.

10 : Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women.

11 : Sonographic depiction of the endometrium during normal cycles.

12 : The Amount of MUC5B mucin in cervical mucus peaks at midcycle.

13 : The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.

14 : Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.

15 : Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model.

16 : Hormonal control of gene expression in the ovary.

17 : Hormonal control of gene expression in the ovary.

18 : Dating the endometrial biopsy

19 : The molecular control of corpus luteum formation, function, and regression.

20 : Neuroendocrine regulation of the corpus luteum in the human. Evidence for pulsatile progesterone secretion.

21 : Serum leptin concentrations during the menstrual cycle in normal-weight women: effects of an oral triphasic estrogen-progestin medication.